|

Combination drug Clinical Trials

2 actively recruiting trials across 1 location

Also known as: CAPOX, FOLFIRI, FOLFOX

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Daiichi Sankyo1
  • Catharina Ziekenhuis Eindhoven1

Indications

  • Cancer2
  • Hematological Malignancies1
  • Recurrent Rectal Cancer1

Other1 trial

Induction Chemotherapy for Locally Recurrent Rectal Cancer
Phase 3

New York, New York1 trial

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.